Cambridge Health Alliance

Cambridge, Massachusetts

OncologyPhase II

What changed

Phase II trial registered: Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

4w agoTrial registeredJun 17, 2026Source filing (opens the source filing in a new tab)

Momentum

74no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
NA registered
Jan 3, 2022
Community Mental Health Services, Adolescent Well Being, Resilience, Psychological, Health Equity, Screening · COMPLETED · sponsor: Cambridge Health Alliance · Prevention and Early Identification for High Risk Youth in School-based Clinics
ClinicalTrials.gov · NCT04935710 (opens the source filing in a new tab)
Trial
PHASE2 registered
Sep 8, 2020
Locally Advanced Unresectable Primary Central Chondrosarcoma, Metastatic Primary Central Chondrosarcoma, Unresectable Primary Central Chondrosarcoma · ACTIVE_NOT_RECRUITING · sponsor: National Cancer Institute (NCI) · Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
ClinicalTrials.gov · NCT04340843 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 73%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Phase II trial registered: Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
4w agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Prevention and Early Identification for High Risk Youth in School-based Clinics
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Prevention and Early Identification for High Risk Youth in School-based Clinics
4mo agoTrial completedSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

NA registered

PHASE2 registered